Wells Criteria: Complete Guide to PE and DVT Scoring

The Wells Criteria for pulmonary embolism (PE) and the Wells Criteria for deep vein thrombosis (DVT) are two separate clinical prediction rules developed by Philip S. Wells and colleagues. Despite sharing a name and an author, they are distinct tools with different parameters, different scoring ranges, different thresholds, and different downstream clinical pathways.

Confusion between the two systems is one of the most common errors in clinical practice and medical education. Applying the PE criteria to evaluate a suspected DVT — or vice versa — leads to incorrect risk stratification and potentially inappropriate diagnostic decisions. This guide addresses each system independently and highlights the key differences.

The Wells PE score was published in Thrombosis and Haemostasis in 2000 (Wells PS et al. Thromb Haemost 2000;83:416-420) and has become the most widely used clinical prediction rule for pre-test probability assessment of pulmonary embolism. The Wells DVT score was published earlier in The Lancet in 1997 (Wells PS et al. Lancet 1997;350:1795-1798) and serves a parallel function for suspected lower extremity deep vein thrombosis.

The Wells PE score comprises seven clinical parameters, yielding a total score that ranges from 0 to 12.5:

Clinical signs and symptoms of DVT (3 points): Leg swelling, pain with palpation of the deep veins.

PE is the most likely diagnosis or equally likely (3 points): This is a clinical gestalt item requiring the physician to consider all available information. It is the most subjective component but also the most heavily weighted.

Heart rate >100 bpm (1.5 points): Tachycardia at the time of assessment.

Immobilization or surgery in the previous 4 weeks (1.5 points): Bed rest for 3 or more consecutive days, or major surgery within 4 weeks.

Previous DVT or PE (1.5 points): Documented prior venous thromboembolism.

Hemoptysis (1 point): Coughing up blood.

Malignancy (1 point): Active cancer (treatment ongoing, within 6 months, or palliative).

The commonly used two-tier interpretation: a score of ≤4 indicates PE unlikely (pre-test probability approximately 8%), while a score of >4 indicates PE likely (pre-test probability approximately 34%). A three-tier model also exists: low (0–1), moderate (2–6), and high (≥7), but the two-tier model is recommended by most current guidelines.

The Wells DVT score uses a partially overlapping but distinct set of clinical parameters, with a different scoring structure:

Active cancer (1 point): Treatment within 6 months or palliative.

Paralysis, paresis, or recent plaster immobilization of the lower extremities (1 point).

Recently bedridden for 3 or more days, or major surgery requiring general or regional anesthesia within the past 12 weeks (1 point). Note: the time frame differs from the PE score (12 weeks vs 4 weeks).

Localized tenderness along the distribution of the deep venous system (1 point).

Entire leg swollen (1 point).

Calf swelling at least 3 cm larger than the asymptomatic side (measured 10 cm below the tibial tuberosity) (1 point).

Pitting edema confined to the symptomatic leg (1 point).

Collateral superficial veins (non-varicose) (1 point).

Previously documented DVT (1 point).

Alternative diagnosis at least as likely as DVT (−2 points): This negative scoring item is critical — it reduces the total score when another diagnosis (cellulitis, Baker's cyst, muscle strain) is clinically plausible.

The two-tier interpretation: a score of ≤1 indicates DVT unlikely (prevalence approximately 5%), while a score of ≥2 indicates DVT likely (prevalence approximately 28%).

The Wells PE score integrates into a structured diagnostic algorithm that has been validated in multiple large prospective studies.

For patients with a Wells PE score ≤4 (PE unlikely), the next step is a high-sensitivity D-dimer assay. If the D-dimer is negative (below the age-adjusted or assay-specific threshold), PE can be safely excluded without imaging. The negative predictive value of this combination exceeds 99% in validation studies. If the D-dimer is positive, CT pulmonary angiography (CTPA) should be performed.

For patients with a Wells PE score >4 (PE likely), proceed directly to CTPA without D-dimer testing. In this population, a negative D-dimer is insufficiently reassuring to exclude PE, and proceeding to imaging avoids the delay and false reassurance of a negative D-dimer in a high pre-test probability population.

In low-risk patients (Wells ≤4) who also meet PERC (Pulmonary Embolism Rule-out Criteria) — age <50, heart rate <100, oxygen saturation ≥95%, no hemoptysis, no estrogen use, no prior VTE, no unilateral leg swelling, and no recent surgery/trauma — PE can be excluded without D-dimer testing. The PERC rule should only be applied to patients who are already in the low pre-test probability category.

Special populations require modified approaches: pregnant patients (D-dimer is physiologically elevated, compression ultrasound before CTPA), patients with renal impairment (V/Q scan may be preferred over contrast-enhanced CTPA), and patients with CT contrast allergy.

The Wells DVT score follows a parallel but distinct diagnostic algorithm.

For patients with a Wells DVT score ≤1 (DVT unlikely), proceed to D-dimer testing. A negative D-dimer safely excludes DVT without the need for ultrasound. If the D-dimer is positive, perform compression ultrasonography of the symptomatic leg.

For patients with a Wells DVT score ≥2 (DVT likely), proceed directly to compression ultrasonography. If the initial ultrasound is negative but clinical suspicion remains high, options include repeating the ultrasound in 5–7 days or performing a D-dimer to guide the need for repeat imaging. A negative D-dimer after a negative ultrasound in a clinically likely patient effectively excludes DVT.

Compression ultrasonography is the imaging modality of choice for suspected DVT. A two-point compression technique (femoral vein at the groin and popliteal vein behind the knee) has sensitivity exceeding 95% for proximal DVT. Whole-leg ultrasound extends to distal (calf) veins but has lower specificity and may detect clinically insignificant thrombi.

The management of isolated distal DVT remains debated. Options include anticoagulation for 3 months (consistent with proximal DVT management) or serial ultrasound surveillance to monitor for proximal extension. Most guidelines recommend anticoagulation for symptomatic distal DVT with risk factors for extension.

The most frequent and clinically significant error with the Wells Criteria is conflating the PE and DVT scoring systems. Several key differences should be committed to memory.

Different parameters: The PE score includes tachycardia (>100 bpm), hemoptysis, and "PE most likely diagnosis" — none of which appear in the DVT score. The DVT score includes physical examination findings (calf circumference difference, pitting edema, collateral veins) and an alternative diagnosis deduction (−2 points) that are not in the PE score.

Different scoring ranges: The PE score ranges from 0 to 12.5 (with fractional points of 1.5), while the DVT score ranges from −2 to 9 (with integer-only scoring).

Different thresholds: PE uses >4 as the cutoff for "likely" (two-tier), while DVT uses ≥2. Applying the PE threshold of >4 to a DVT assessment would incorrectly classify patients with scores of 2–4 as "unlikely," potentially leading to missed diagnoses.

Different downstream pathways: A "likely" PE triggers CTPA, while a "likely" DVT triggers compression ultrasonography. These are fundamentally different diagnostic modalities with different radiation exposure, contrast requirements, and availability.

Clinical decision support tools that clearly distinguish between these two scoring systems — presenting the correct parameters, thresholds, and downstream pathways for each — help prevent these errors. In AttendMe.ai, the Wells PE and Wells DVT calculators are separate tools, each with their own validated parameters and interpretation guidance.

Effective use of the Wells Criteria requires embedding them within a structured clinical approach rather than applying them in isolation.

First, determine which scoring system applies. If the clinical question is whether a patient has a pulmonary embolism, use the Wells PE score. If the question is whether they have a lower extremity DVT, use the Wells DVT score. In patients presenting with both leg symptoms and respiratory symptoms, both scores should be calculated independently to guide separate diagnostic pathways.

Second, calculate the score systematically. The subjective components — "PE is the most likely diagnosis" for the PE score, and "alternative diagnosis at least as likely" for the DVT score — require deliberate clinical reasoning. Document your rationale for these items, as they significantly influence the total score and subsequent management.

Third, follow the validated algorithm. The Wells Criteria are most powerful when used as part of the complete diagnostic pathway (Wells score plus D-dimer plus imaging), not as standalone decision tools. A Wells PE score of 3 means PE is unlikely, but the diagnosis is not excluded until a negative D-dimer confirms low risk.

Fourth, recognize the limitations. The Wells Criteria were validated in ambulatory ED and outpatient populations. Their performance may differ in hospitalized patients, post-surgical patients, pregnant patients, and patients with prior VTE — populations where clinical judgment and modified pathways should supplement the score.

Platforms like AttendMe.ai integrate the Wells PE and DVT calculators directly into the clinical question workflow. Asking about PE risk assessment automatically surfaces the Wells PE calculator with its specific parameters and the appropriate downstream pathway, while a DVT-related question triggers the Wells DVT calculator — ensuring the correct tool is applied to the correct clinical question.